State

Nebraska product recalls

73,833 recalls have nationwide distribution and so reach Nebraska. 4,580 additional recalls listed Nebraska specifically in their distribution scope.

What the numbers show

Total: 4,580
Critical: 713
Severe: 1,345
Most recent: 2026-10-28

Of the 4,580 recalls naming Nebraska we have scored against our rubric, 713 (16%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 1,345 (29%) are Severe.

Which agencies issued them

These figures cover only the 4,580 recalls whose distribution notice names Nebraska specifically. The 73,833 nationwide recalls listed below reach every state, so counting them here would make every state page show the same numbers.

58176–58200 of 78413

HighFDA (Drugs)·D-847-2015·2015-04-29
Attix Pharmaceuticals Recalls Polidocanol Due to Penicillin Cross Contamination Risk
Attix Pharmaceuticals is recalling Polidocanol active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Polidocanol active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-894-2015·2015-04-29
Silver Sulfadiazine Recalled for Potential Penicillin Cross Contamination
Attix Pharmaceuticals is recalling Silver Sulfadiazine active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Silver Sulfadiazine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-905-2015·2015-04-29
Sucralfate API Recalled for Potential Penicillin Cross Contamination
Attix Pharmaceuticals is recalling sucralfate active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Sucralfate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
HighFDA (Devices)·Z-1489-2015·2015-04-29
Wright Medical Recalls Crosscheck Plating System Due to Dimensional Defects
Wright Medical Technology is recalling 242 units of the Crosscheck Plating System because dimensional specifications are out of range, posing a risk of intraoperative malfunction.
Product
CROSSCHECK(R) Plating system, LAPIDUS CX plate, 2mm Step, Right, REF CCP-LPX2R. Orthopedic use.
Category
Medical Device
Distribution
Distributed nationwide
HighFDA (Drugs)·D-780-2015·2015-04-29
Attix Pharmaceuticals Recalls Metaxalone API Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Metaxalone active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Metaxalone active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
HighFDA (Devices)·Z-1478-2015·2015-04-29
Churchill Medical Systems Recalls 6-inch Trifurcated Sets with Bionectors
Churchill Medical Systems is recalling 1,650 6-inch trifurcated sets with Bionectors due to a potential leak caused by insufficient bonding between the needleless device and the female luer.
Product
6" Trifurcated set with Bionectors, Product Code: BN-944 Accessory device used to administer medical fluids
Category
Medical Device
Distribution
Distributed nationwide
HighFDA (Drugs)·D-528-2015·2015-04-29
Atovaquone API Recalled for Potential Penicillin Cross-Contamination
Attix Pharmaceuticals is recalling Atovaquone active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Atovaquone active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-618-2015·2015-04-29
Attix Pharmaceuticals Recalls Demecarium Bromide Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Demecarium Bromide active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Demecarium Bromide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-724-2015·2015-04-29
Attix Pharmaceuticals Recalls Hydroxyzine HCl Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Hydroxyzine HCl active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Hydroxyzine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-688-2015·2015-04-29
Flurbiprofen API Recalled for Potential Penicillin Cross-Contamination
Attix Pharmaceuticals is recalling flurbiprofen active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Flurbiprofen active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
HighFDA (Devices)·Z-1487-2015·2015-04-29
Wright Medical Recalls Crosscheck Plating System Due to Specification Defects
Wright Medical Technology is recalling 142 units of the Crosscheck Plating system because dimensional specifications are out of tolerance, posing a risk of intraoperative malfunction.
Product
CROSSCHECK(R) Plating system, LAPIDUS CX Plate, 1mm Step, Right, REF CCP-LPX1R. Orthopedic use.
Category
Medical Device
Distribution
Distributed nationwide
HighFDA (Drugs)·D-666-2015·2015-04-29
Attix Pharmaceuticals Recalls Etoposide Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Etoposide active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Etoposide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-585-2015·2015-04-29
Attix Pharmaceuticals Recalls Cilostazol API Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling cilostazol active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Cilostazol active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-561-2015·2015-04-29
Attix Pharmaceuticals Recalls Carbimazole Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Carbimazole active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Carbimazole active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-538-2015·2015-04-29
Attix Pharmaceuticals Recalls Benoxinate HCl Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Benoxinate HCl active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Benoxinate HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
HighFDA (Devices)·Z-1484-2015·2015-04-29
Wright Medical Recalls Crosscheck Plating System Due to Specification Defects
Wright Medical Technology is recalling 128 units of the Crosscheck Plating System because dimensional specifications are out of range, posing a risk of intraoperative malfunction.
Product
CROSSCHECK(R) Plating system, LAPIDUS CX Plate, NEUTRAL, Left, REF CCP-LPX0L. Orthopedic use.
Category
Medical Device
Distribution
Distributed nationwide
HighFDA (Drugs)·D-769-2015·2015-04-29
Attix Pharmaceuticals Recalls Loratadine API Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Loratadine active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Loratadine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-778-2015·2015-04-29
Attix Pharmaceuticals Recalls Memantine HCl Due to Penicillin Cross Contamination Risk
Attix Pharmaceuticals is recalling Memantine HCl active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Memantine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-581-2015·2015-04-29
Attix Pharmaceuticals Recalls Chlorpromazine HCl Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Chlorpromazine HCl active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Chlorpromazine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
HighFDA (Devices)·Z-1477-2015·2015-04-29
Churchill Medical Systems Recalls 4-inch Trifurcated Sets Due to Leaking Risk
Churchill Medical Systems is recalling 2,650 units of 4-inch trifurcated sets with Bionectors and check valves due to a potential for leaking caused by insufficient bonding.
Product
4" Trifurcated set with Bionectors and check valves, Product Code: BN-3082CV and BN-3083CV Accessory device used to administer medical fluids
Category
Medical Device
Distribution
Distributed nationwide
HighFDA (Drugs)·D-609-2015·2015-04-29
Attix Pharmaceuticals Recalls Dacarbazine Due to Penicillin Cross Contamination Risk
Attix Pharmaceuticals is recalling Dacarbazine active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Dacarbazine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-938-2015·2015-04-29
Attix Pharmaceuticals Recalls Tranexamic Acid Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Tranexamic Acid active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Tranexamic Acid active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
HighFDA (Devices)·Z-1491-2015·2015-04-29
Wright Medical Recalls Crosscheck Plating System Due to Dimensional Defects
Wright Medical Technology is recalling 301 units of the Crosscheck Plating System because dimensional specifications are out of range, posing a risk of intraoperative malfunction.
Product
CROSSCHECK(R) Plating system, MTP NX Plate, Right, Recon, REF CCP-MPN2R. Orthopedic use.
Category
Medical Device
Distribution
Distributed nationwide
HighFDA (Drugs)·D-914-2015·2015-04-29
Attix Pharmaceuticals Recalls Tamsulosin Base Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Tamsulosin Base active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Tamsulosin Base active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-703-2015·2015-04-29
Attix Pharmaceuticals Recalls Heparin Sodium Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Heparin Sodium active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Heparin Sodium active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide